An endocrinologist gives a general explainer on who these weight loss injections may suit and how they work, aimed at people with obesity or constant hunger.
Recap by typeshit. Post by @dr_vishnu_endocrinologist on Instagram.
She says certain foods prompt the gut to release GLP1 and PYY, which she credits with fullness and slower digestion. A recipe post, not drug news.
Novo's India head Vikrant Shrotriya gave the timing on October 15. EU advisers also backed a revised Kyinsu label for type 2 diabetes, with a final EC decision pending.
The Darling Ingredients unit says the supplement ingredient concentrates over ten neurosupportive peptides, with clinical trials planned to start in December.
The plastic surgeon weighs in on semaglutide and other GLP-1 drugs as more patients of every age turn to them for major weight loss.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
Loading…